Haley Urbach

Haley Urbach

Auto-generated profile, based on publicly available information

Haley Urbach

Department of Pediatrics, Section of General Pediatrics Yale University New Haven Connecticut USA

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 June 2025 in Pediatric Pulmonology
Verified
Journal Article
Closed access
HUHaley Urbach
Haley Urbach
SOSharon Ostfeld‐Johns
Sharon Ostfeld‐Johns
SMSarah McCollum
Sarah McCollum
PWPnina Weiss
Pnina Weiss
SKSarah Kandil
Sarah Kandil
EBEliaz Brumer
Eliaz Brumer

26 August 2025 in Pediatric Pulmonology
Verified
Journal Article
Closed access
EBEliaz Brumer
Eliaz Brumer
VSVeronika Shabanova
Veronika Shabanova
HUHaley Urbach
Haley Urbach
AMAngela Montgomery
Angela Montgomery
MGMatthew Grossman
Matthew Grossman
SKSarah Kandil
Sarah Kandil

4 March 2024 in The Pediatric Infectious Disease Journal
Verified
Journal Article
Closed access
HUHaley Urbach
Haley Urbach
NSNicole Sileo
Nicole Sileo
SLSergio Lerma
Sergio Lerma
KNKevin Nguyen
Kevin Nguyen
GSGiordano Sosa Soto
Giordano Sosa Soto
JCJeffrey I. Campbell
Jeffrey I. Campbell
Background: Managing health care acquired and device-associated intracranial infections in young children can be challenging given adverse antibiotic side effects and difficulties in achieving adequate central nervous system (CNS) antibiotic concentrations. Ceftaroline is a cephalosporin with a favorable safety profile and activity against methicillin-resistant Staphylococci and several Gram-negative organisms. Published data on the use of ceftaroline for CNS infections in children and adults are limited. Methods: We describe a 2-month-old infant with ventriculo-subgaleal shunt-associated methicillin-resistant Staphylococcus epidermidis ventriculitis, which was successfully treated with ceftaroline, in addition to vancomycin and rifampin. We conducted a scoping review of English-language literature retrieved from PubMed, EMBASE and Web of Science that assessed the use of ceftaroline for CNS infections. Results: We identified 22 articles for inclusion in our review, which described 92 unique patients, of whom 2 were <21 years old. Ceftaroline was commonly used in conjunction with other antibiotics to treat infections caused by Staphylococcus aureus, coagulase-negative Staphylococci and Streptococcus pneumoniae. Most case reports described clinical success with ceftaroline, though small case series and cohort studies yielded mixed efficacy assessments. Adverse effects attributed to ceftaroline were rare and included reversible myelosuppression, eosinophilia, hepatotoxicity and nephrotoxicity. Pharmacokinetic/pharmacodynamic studies suggested similar CNS penetration through inflamed meninges as other beta lactam antibiotics. Conclusions: We identified a growing body of published evidence supporting the use of ceftaroline in combination with other agents for the treatment of CNS infections. In absence of clinical trials, additional real-world data are needed to define the efficacy and safety of ceftaroline for children and adults with CNS infections.

5 December 2025 in Pediatric Emergency Care
Verified
Journal Article
Closed access
TFTomeka Frieson
Tomeka Frieson
LTLilin Tong
Lilin Tong
SGSanil Gandhi
Sanil Gandhi
NSNishita Sunkara
Nishita Sunkara
HUHaley Urbach
Haley Urbach
RTRachel Thompson
Rachel Thompson
Objectives: Adolescence is a critical period of growth and development, shaped by the social conditions in which youth are immersed. Many adolescents use emergency departments (EDs) as their primary source of care, often bypassing routine health care systems where preventative screenings and counseling are provided. This may lead to missed opportunities to address social or mental health needs. Partners in Equity and Empowerment through Resources and Support (PEERS), based out of Boston Medical Center’s pediatric ED, bridges the gap between patients’ health-seeking behaviors and the ED’s capacity to provide preventive care. PEERS engages medical and public health students to conduct social and mental health screenings, connecting adolescent and young-adult (AYA) patients with community-based resources that support their holistic health needs. Methods: From 2021 to 2023, medical and public health students performed bedside screenings of 13- to 23-year-old pediatric ED patients using a blended survey developed from validated screening tools for social drivers of health (SDoH) (e.g., food insecurity, housing, employment, sexual health, substance use) and mental health. Following verbal consent/assent, survey screenings, and brief negotiated interviews, patients were referred to curated, need-specific resources for further support. Results: During our 28-month pilot, 246 AYA patients were screened, with 97.2% reporting at least one SDoH need and 93.1% referred to at least one community-based resource. The most commonly requested resources were education (46.3%), employment (38.6%), and mental health (32.9%). Younger age was associated with higher requests for educational resources (OR: 1.38; 95% CI: 1.10-1.79), while male gender was linked to fewer mental health resource requests (OR: 0.27; 95% CI: 0.07–0.88). Conclusions: An interprofessional, student-led team can provide AYA patients with the necessary SDoH resources to bridge care gaps without disrupting ED workflow, supporting the feasibility and benefit of this innovative program to promote health.